These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24331184)

  • 1. Diabetes and pancreatic cancer.
    Chaudhry ZW; Hall E; Kalyani RR; Cosgrove DP; Yeh HC
    Curr Probl Cancer; 2013; 37(5):287-92. PubMed ID: 24331184
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetes and pancreatic cancer.
    Muniraj T; Chari ST
    Minerva Gastroenterol Dietol; 2012 Dec; 58(4):331-45. PubMed ID: 23207610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes and pancreatic cancer.
    Cui Y; Andersen DK
    Endocr Relat Cancer; 2012 Oct; 19(5):F9-F26. PubMed ID: 22843556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes and cancer: placing the association in perspective.
    Andersen DK
    Curr Opin Endocrinol Diabetes Obes; 2013 Apr; 20(2):81-6. PubMed ID: 23422245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes and cancer: 5 years into the recent controversy.
    Badrick E; Renehan AG
    Eur J Cancer; 2014 Aug; 50(12):2119-25. PubMed ID: 24930060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is type 2 diabetes a risk factor for pancreatic cancer?
    Pezzilli R; Casadei R; Morselli-Labate AM
    JOP; 2009 Nov; 10(6):705-6. PubMed ID: 19890202
    [No Abstract]   [Full Text] [Related]  

  • 7. The Impact of obesity and diabetes mellitus on pancreatic cancer: Molecular mechanisms and clinical perspectives.
    Quoc Lam B; Shrivastava SK; Shrivastava A; Shankar S; Srivastava RK
    J Cell Mol Med; 2020 Jul; 24(14):7706-7716. PubMed ID: 32458441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of diabetes and antidiabetic medications on the risk of pancreatic cancer: a nationwide population-based study in Korea.
    Lee DY; Yu JH; Park S; Han K; Kim NH; Yoo HJ; Choi KM; Baik SH; Kim NH; Seo JA
    Sci Rep; 2018 Jun; 8(1):9719. PubMed ID: 29946194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin use among type 2 diabetics and risk of pancreatic cancer in a clinic-based case-control study.
    Walker EJ; Ko AH; Holly EA; Bracci PM
    Int J Cancer; 2015 Mar; 136(6):E646-53. PubMed ID: 25091126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pancreatic cancer--association with diabetes mellitus and smoking].
    Díte P; Trna J; Belobrádková J; Novotný I; Hermanová M; Vlcková P; Klímová K; Kianicka B; Lemine A; Liberda M; Geryk E
    Vnitr Lek; 2011 Feb; 57(2):159-62. PubMed ID: 21416856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Insulin treatment in type 2 diabetes].
    Birkeland KI
    Tidsskr Nor Laegeforen; 2006 Mar; 126(7):919-20. PubMed ID: 16554885
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diabetes and cancer risk: oncologic considerations].
    Rosta A
    Orv Hetil; 2011 Jul; 152(29):1144-55. PubMed ID: 21712179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort.
    Baur DM; Klotsche J; Hamnvik OP; Sievers C; Pieper L; Wittchen HU; Stalla GK; Schmid RM; Kales SN; Mantzoros CS
    Metabolism; 2011 Oct; 60(10):1363-71. PubMed ID: 21081242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with incretins does not increase the risk of pancreatic diseases compared to older anti-hyperglycaemic drugs, when added to metformin: real world evidence in people with Type 2 diabetes.
    Montvida O; Green JB; Atherton J; Paul SK
    Diabet Med; 2019 Apr; 36(4):491-498. PubMed ID: 30306620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. As the worm turns. On diabetes and obesity.
    Gottlieb SH
    Diabetes Forecast; 2002 Apr; 55(4):25-7. PubMed ID: 14959687
    [No Abstract]   [Full Text] [Related]  

  • 16. Hyperinsulinemia and risk for hepatocellular carcinoma in patients with chronic liver diseases and Type 2 diabetes mellitus.
    Donadon V; Balbi M; Zanette G
    Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):465-7. PubMed ID: 19817667
    [No Abstract]   [Full Text] [Related]  

  • 17. Diabetes mellitus as a novel risk factor for gastrointestinal malignancies.
    Herrigel DJ; Moss RA
    Postgrad Med; 2014 Oct; 126(6):106-18. PubMed ID: 25414939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes and pancreatic cancer.
    Li D
    Mol Carcinog; 2012 Jan; 51(1):64-74. PubMed ID: 22162232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes mellitus and increased risk of cancer: focus on metformin and the insulin analogs.
    McFarland MS; Cripps R
    Pharmacotherapy; 2010 Nov; 30(11):1159-78. PubMed ID: 20973689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New strategies in pancreatic cancer: emerging epidemiologic and therapeutic concepts.
    Li D; Abbruzzese JL
    Clin Cancer Res; 2010 Sep; 16(17):4313-8. PubMed ID: 20647474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.